Lv1
80 积分 2025-09-15 加入
Radical Prostatectomy Without Biopsy: Audacious, Imprudent, or Innovative?
2小时前
待确认
IP42-12 PRIMARY RPLND OR CHEMOTHERAPY FOR MARKER-POSITIVE CLINICAL STAGE II NSGCT: A COMPARATIVE ANALYSIS
8天前
已完结
IP42-12 PRIMARY RPLND OR CHEMOTHERAPY FOR MARKER-POSITIVE CLINICAL STAGE II NSGCT: A COMPARATIVE ANALYSIS
8天前
已关闭
IP42-12 PRIMARY RPLND OR CHEMOTHERAPY FOR MARKER-POSITIVE CLINICAL STAGE II NSGCT: A COMPARATIVE ANALYSIS
8天前
已关闭
Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis
24天前
已完结
前列腺穿刺中国专家共识(2022年版)
1个月前
已完结
Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
1个月前
已关闭
Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
1个月前
已关闭
A cost-effectiveness study of PSMA-PET/CT for the detection of clinically significant prostate cancer
1个月前
已完结
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection
1个月前
已完结
皖公网安备34019202002308
